A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma

Cancer Genetics and Cytogenetics

Volumn 175, Issue 1, 2007, Pages 73-76

  La Starza, Roberta ^a   Crescenzi, Barbara ^a   Pierini, Valentina ^a   Romoli, Silvia ^a   Gorello, Paolo ^a   Brandimarte, Lucia ^a   Matteucci, Caterina ^a   Kropp, Maria Grazia ^b   Barba, Gianluca ^a   Martelli, Massimo Fabrizio ^a   Mecucci, Cristina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYOTUBULARIN RELATED PROTEIN 11; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER PATIENT; CASE REPORT; CENTROMERE; CHILD; CHROMOSOME 1Q; CHROMOSOME DUPLICATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; HUMAN; KARYOTYPE; LEUKEMOGENESIS; MALE; MTMR11 GENE; ONCOGENE; OTUD7B GENE; PRIORITY JOURNAL; SF3B4 GENE; TELOMERE; TUMOR SUPPRESSOR GENE;

BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENE DUPLICATION; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; RNA-BINDING PROTEINS;

EID: 34247897129     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.01.011     Document Type: Article

References (18)

1. Bench A.J., Cross N.C.P., Huntly B.J.P., Nacheva E.P., and Green A.R. Myeloproliferative disorders. Best Pract Res Clinic Haematol 14 (2001) 531-551
2. Hanamura I., Stewart J.P., Huang Y., Zhan F., Santra M., Sawyer J.R., Hollmig K., Zangarri M., Pineda-Roman M., van Rhee F., Cavallo F., Burington B., Crowley J., Tricot G., Barlogie B., and Shaughnessy Jr. J.D. Frequent gain of chromosome band 1q21 in plasma cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem cell transplantation. Blood 108 (2006) 1724-1732
3. Berger R., and Bernheim A. Cytogenetic studies on Burkitt's lymphoma-leukemia. Cancer Genet Cytogenet 7 (1982) 231-244
4. Offit K., Wong G., Filippa D.A., Tao Y., and Chaganti R.S.K. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 77 (1991) 1508-1515
5. ISCN 2005: an international system for human cytogenetic nomenclature (2005). In: Shaffer LG, Tommerup N, editors. Basel: S. Karger, 2005.
6. Dierlamm J., Wlodarska I., Michaux L., La Starza R., Zeller W., Mecucci C., and Van den Berghe H. Successful use of the same slide for consecutive fluorescence in situ hybridization (FISH) experiments. Genes Chromosomes Cancer 16 (1996) 261-264
7. Entrez Gene database. Available at: http://www.ncbi.nlm.nih.gov/entrez/query (build 36.2). Accessed April 16, 2007.
8. La Starza R., Aventin A., Falzetti D., Wlodarska I., Fernandez Peralta A.M., Gonzales-Aguilera J.J., Ciolli S., Martelli M.F., and Mecucci C. Regions of juxtaposition in unbalanced 1q rearrangements of malignant hemopathies. Leukemia 15 (2001) 861-863
9. Knight S.J.L., Lese C.M., Precht K.S., Kuc J., Ning Y., Lucas S., Regan R., Brenan M., Nicod A., Lawrie N.M., Cardy D.L.N., Nguyen H., Hudson T.J., Riethman H.C., Ledbetter D.H., and Flint J. An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet 67 (2000) 320-332
10. Busson-Le Coniat M., Salomon-Nguyen F., Dastugue N., Maarek O., Lafage-Pochitaloff M., Mozziconacci M.-J., Baranger L., Brizard F., Radford I., Jeanpierre M., Bernard O.A., and Berger R. Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations. Leukemia 13 (1999) 1975-1981
11. Evans P.C., Smith T.S., Lai M.-J., Williams M.G., Barker D.F., Heyninck K., Kreike M.M., Beyaert R., Blundell T.L., and Kilshaw P.J. A novel type of deubiquitinating enzyme. J Biol Chem 278 (2003) 23180-23186
12. Karin M., Cao Y., Greten F.R., and Li Z.-W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev 2 (2002) 301-310
13. Wishart M.J., Taylor G.S., Slama J.T., and Dixon J.E. PTEN and myotubularin phosphoinositide phosphastases: bringing bioinformatics to the lab bench. Curr Opin Cell Biol 13 (2001) 172-181
14. Laporte J., Hu L.J., Kretz C., Mandel J.L., Kioschis P., Coy J.F., Klauck S.M., Poustka A., and Dahl N. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13 (1996) 175-182
15. Bolino A., Muglia M., Conforti F.L., LeGuern E., Salih M.A., Georgiou D.M., Christodoulou K., Hausmanowa-Petrusewicz I., Mandich P., Schenone A., Gambardella A., Bono F., Quattrone A., Devoto M., and Monaco A.P. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25 (2000) 17-19
16. Azzedine H., Bolino A., Taieb T., Birouk N., Di Duca M., Bouhouche A., Benamou S., Mrabet A., Hammadouche T., Chkili T., Gouider R., Ravazzolo R., Brice A., Laporte J., and LeGuern E. Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet 72 (2003) 1141-1153
17. Chan NPH, NG MHL, Cheng SH, Lee V, Tsang KS, Lau TT, Li CK. Hereditary duplication of proximal chromosome 1q(q11q22) in a patient with T lymphoblastic lymphoma/leukemia: a family study using G banding and comparative genomic hybridization. J Med Genet 2002;39:79-82.
18. Ghose T., Lee C.L., Fernandez L.A., Lee S.H., Raman R., and Colp P. Role of 1q trisomy in tumorigenicity, growth, and metastasis of human leukemic B-cell clones in nude mice. Cancer Res 50 (1990) 3737-3742